COVID-19 news is changing rapidly and we are all trying to stay on top of the latest medical information from trusted sources. Join experts in the medical field for free CME webinars covering what we know about the coronavirus outbreak.
3/25/2020 - COVID-19: Keeping Up With A Moving Target
Join us in a follow up to last week's webcast - COVID-19: Keeping Up with a Moving Target and the first of our new coronavirus educational activities as part of DKBmed's Radio Hour. Today Dr. Auwaerter provides us with updates on infection rates, therapeutics, and testing. Plus, he answers your questions about topics such as proper protective equipment, use of ibuprofen with COVID-19, and pregnancy.
Paul G. Auwaerter, MD, MBA, FIDSA
Clinical Director, Division of Infectious Diseases
Sherrilyn and Ken Fisher Professor of Medicine
Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Enduring Internet Activity
The enduring material will be available from March 18, 2020 to March 18, 2021.ACPE Release date: 3/18/2020Jointly provided by Postgraduate Institute for Medicine and DKBmedEstimated time to complete this activity: 1 hour 15 minutes
This activity is intended for health care providers in the care of patients with COVID-19.
After completing this activity, the participant should be better able to:
Discuss symptoms and transmission of COVID-19
Discuss risks, management, and precautions associated with COVID-19
Describe natural history of COVID-19 illness
Paul G Auwaerter, MD, MBA, FIDSA
Past President of the Infectious Diseases Society of America (IDSA)
Professor of Medicine
Johns Hopkins University School of Medicine
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-20-2034-H01-P)Type of Activity: KnowledgeHardware/Software Requirements Include minimum hardware, software, internet connectivity and connection speed requirements for accessing the internet-based activity.Policy on Privacy and Confidentiality Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.AAPA Credit DesignationPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.Continuing Nursing EducationThe maximum number of hours awarded for this Continuing Nursing Education activity is 1.2 contact hours.Disclosure of Conflicts of InterestPostgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty / Presenter Reported Financial Relationship Paul G. Auwaerter, MD, MBA, FIDSA
Scientific Advisor: DiaSaorin, Shionogi Inc.
Ownership Equity: JNPPlanners and Managers
The PIM planners and managers have nothing to disclose. The DKBmed planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity. During the period of March 18, 2020 through March 18, 2021, participants must read the learning objectives and faculty disclosures and study the educational activity.If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 15284. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.